Literature DB >> 20309703

[Measuring quality of life in rheumatic disease. A critical appraisal].

T Meyer1, H Raspe.   

Abstract

The term quality of life (QoL) has been introduced to account for relevant non-clinical endpoints and the integration of patients' perspectives into treatment evaluation, amongst others. However, QoL is not a uniform, consistent scientific concept but an equivocal generic term for a field of interest. It can relate to such diverse aspects as living conditions, functioning, perception or appraisal of health-related states or general aspects of life. Any assessment of QoL must necessarily exclude relevant facets and assume comparability of basic important life themes in specific groups of people. Widespread instruments for QoL assessment in rheumatology, e.g. SF-36, EQ-5D or the Nottingham Health Profile, represent different QoL concepts (profiles vs. indices). However, they have in common a societal ideal of a physically capable, mentally healthy, socially integrated and functionally competent person. Before an assessment of QoL the aims of an assessment and the concepts of interest should be specified.

Entities:  

Mesh:

Year:  2010        PMID: 20309703     DOI: 10.1007/s00393-009-0570-z

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  11 in total

1.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

Review 2.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

3.  Therapeutic criteria in rheumatoid arthritis.

Authors:  O STEINBROCKER; C H TRAEGER; R C BATTERMAN
Journal:  J Am Med Assoc       Date:  1949-06-25

Review 4.  The ICF as a conceptual platform to specify and discuss health and health-related concepts.

Authors:  A Cieza; J Bickenbach; S Chatterji
Journal:  Gesundheitswesen       Date:  2008-10-17

Review 5.  [Health related quality of life and subjective health. Overview of the status of research for new evaluation criteria in medicine].

Authors:  M Bullinger
Journal:  Psychother Psychosom Med Psychol       Date:  1997 Mar-Apr

Review 6.  [Outcome parameters in ankylosing spondylitis].

Authors:  H Haibel; M Rudwaleit; J Sieper
Journal:  Z Rheumatol       Date:  2006-03       Impact factor: 1.372

Review 7.  Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis.

Authors:  Quan V Doan; Chiun-Fang Chiou; Robert W Dubois
Journal:  J Manag Care Pharm       Date:  2006-09

8.  [German version of the Nottingham Health Profile (NHP): translation and psychometric validation].

Authors:  T Kohlmann; M Bullinger; I Kirchberger-Blumstein
Journal:  Soz Praventivmed       Date:  1997

9.  Benefits of total hip replacement to older patients and the community.

Authors:  G K Wilcock
Journal:  Br Med J       Date:  1978-07-01

Review 10.  Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials.

Authors:  Vibeke Strand; Jasvinder A Singh
Journal:  Am J Manag Care       Date:  2008-04       Impact factor: 2.229

View more
  1 in total

Review 1.  [Treat-to-target (T2T) from the perspective of inpatient rheumatology].

Authors:  H-J Lakomek; A Krause
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.